Evotec Adjusts Revenue Guidance for 2025

Evotec SE has revised its revenue projections for 2025, anticipating between €760 million and €800 million, down from the previously forecasted €840 million to €880 million. Despite this adjustment, the company maintains its guidance for R&D expenditures and adjusted EBITDA, expecting significant contributions from high-margin technology licenses.

The company's new strategy for sustainable growth is reportedly on track, despite a challenging market environment for its shared R&D base business. CEO Dr. Christian Wojczewski indicates that this strategy, along with a priority reset, is expected to enhance cost efficiency and profitability.

Evotec's outlook for 2028 remains unchanged, with a projected compound annual growth rate of 8-12% in group revenues and an adjusted EBITDA margin exceeding 20% by 2028.